(Q44208458)

30 November 2017

title

Affinities of dihydrocodeine and its metabolites to opioid receptors (English)

1 reference

30 November 2017

0 references

4

Ursula Gundert-Remy

1 reference

30 November 2017

Helmut Schmidt

1

1 reference

30 November 2017

Stefan v Vormfelde

2

1 reference

30 November 2017

Klaus Klinder

3

1 reference

30 November 2017

Christoph H Gleiter

5

1 reference

30 November 2017

Gisela Skopp

6

1 reference

30 November 2017

Rolf Aderjan

7

1 reference

30 November 2017

Uwe Fuhr

8

1 reference

30 November 2017

publication date

1 August 2002

1 reference

Basic and Clinical Pharmacology and Toxicology

30 November 2017

published in

1 reference

30 November 2017

volume

91

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

57-63

1 reference

Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosing

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

the apparent affinity of morphine-3-glucuronide at μ1-opioid receptors results from morphine contamination: demonstration using HPLC and radioligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

Mu receptor binding of some commonly used opioids and their metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

[Codeine and dihydrocodeine as substitute and alternative drugs]

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

Dihydrocodeine: a new opioid substrate for the polymorphic CYP2D6 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

"It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

[3H]U-69593 a highly selective ligand for the opioid kappa receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

Morphine-6-glucuronide: an analgesic of the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

Molecular mechanisms of genetic polymorphisms of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

The binding properties of the particulate and solubilized sulfonylurea receptor from cerebral cortex are modulated by the Mg2+ complex of ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

Exploration of the metabolism of dihydrocodeine via determination of its metabolites in human urine using micellar electrokinetic capillary chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910203.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1034/J.1600-0773.2002.910203.X

1 reference

30 November 2017

1 reference